BARICORDI, Olavio
 Distribuzione geografica
Continente #
NA - Nord America 12.673
AS - Asia 6.745
EU - Europa 6.127
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 146
OC - Oceania 16
Totale 26.857
Nazione #
US - Stati Uniti d'America 12.374
IT - Italia 2.857
SG - Singapore 2.353
CN - Cina 2.073
DE - Germania 816
BR - Brasile 748
UA - Ucraina 729
VN - Vietnam 674
HK - Hong Kong 500
TR - Turchia 381
GB - Regno Unito 365
FI - Finlandia 337
FR - Francia 233
RU - Federazione Russa 190
JP - Giappone 154
CA - Canada 150
IN - India 141
SE - Svezia 137
BD - Bangladesh 122
NL - Olanda 118
PL - Polonia 114
MX - Messico 88
AR - Argentina 62
IQ - Iraq 50
ZA - Sudafrica 50
ID - Indonesia 49
AT - Austria 42
EC - Ecuador 41
CO - Colombia 37
ES - Italia 34
TH - Thailandia 30
BE - Belgio 29
UZ - Uzbekistan 28
MA - Marocco 26
PK - Pakistan 26
VE - Venezuela 23
PH - Filippine 21
LT - Lituania 19
CH - Svizzera 18
MY - Malesia 18
SA - Arabia Saudita 18
CL - Cile 17
CZ - Repubblica Ceca 17
CR - Costa Rica 15
AE - Emirati Arabi Uniti 14
AU - Australia 14
EG - Egitto 14
IR - Iran 14
IE - Irlanda 13
KE - Kenya 11
PE - Perù 11
JM - Giamaica 10
PY - Paraguay 10
RO - Romania 9
IL - Israele 8
KZ - Kazakistan 8
LB - Libano 8
MD - Moldavia 8
OM - Oman 8
TN - Tunisia 8
AZ - Azerbaigian 7
BO - Bolivia 7
AL - Albania 6
ET - Etiopia 6
KR - Corea 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BB - Barbados 5
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
JO - Giordania 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
BG - Bulgaria 4
NI - Nicaragua 4
NP - Nepal 4
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BH - Bahrain 2
BJ - Benin 2
CG - Congo 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
KW - Kuwait 2
PR - Porto Rico 2
Totale 26.648
Città #
Singapore 1.480
Ashburn 1.152
Woodbridge 1.029
San Jose 986
Fairfield 917
Jacksonville 718
Chandler 713
Houston 657
Beijing 575
Santa Clara 544
Hong Kong 492
Wilmington 378
Ann Arbor 375
Seattle 367
Hangzhou 325
Milan 313
Council Bluffs 307
Cambridge 292
New York 284
Ho Chi Minh City 241
Rome 241
Izmir 213
Munich 209
Los Angeles 194
Nanjing 189
Dallas 180
Tokyo 149
Princeton 146
Helsinki 136
Hanoi 131
Boardman 123
Lauterbourg 113
Warsaw 103
Addison 99
Shenyang 83
São Paulo 83
San Diego 79
The Dalles 72
Mexico City 70
Shanghai 70
Toronto 67
Buffalo 66
Dearborn 63
Orem 63
Nanchang 62
Naples 60
Bologna 58
Ferrara 54
Turku 53
Hebei 52
Turin 52
Hefei 45
Chennai 43
Changsha 42
Tianjin 41
Bremen 40
Brooklyn 40
Falkenstein 40
London 39
Montreal 37
Verona 37
Bari 35
Chicago 35
Florence 35
Vienna 35
Denver 34
Frankfurt am Main 34
Jiaxing 34
Falls Church 33
Haiphong 32
Norwalk 30
San Mateo 30
Palermo 29
Da Nang 28
Kunming 27
Rio de Janeiro 27
Bangkok 26
Johannesburg 26
Manchester 26
Mountain View 26
Philadelphia 26
Stockholm 26
Tashkent 25
Brussels 24
Atlanta 23
Baghdad 23
Moscow 23
Redwood City 23
Amsterdam 22
Augusta 22
Mumbai 22
Brescia 20
Phoenix 20
Jinan 19
San Francisco 19
Boston 18
Guangzhou 18
Modena 18
Zhengzhou 18
Charlotte 16
Totale 16.889
Nome #
Mutazione Q283P nel gene HFE in un eterozigote C282Y affetto da emocromatosi. 1.705
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.344
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 429
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 427
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 331
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 305
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 261
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 259
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 257
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 254
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 248
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 248
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 247
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 241
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 238
Emerging topics and new perspectives on HLA-G 235
The antibiotic polymyxin B modulates P2X7 receptor function 232
Analisi del polimorfismo IVS2+4T>C del gene HFE in soggetti con sovraccarico di ferro. 224
Purinoceptor function in the immune system 223
A novel mutation of HFE explains the classical phenotype of hereditary hemochromatosis in a C282Y carrier 223
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 219
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 219
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 218
HLA-G expression is a fundamental prerequisite to pregnancy 214
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 212
Antigenes sHLA-G et polypose naso-sinusienne. 212
The antibiotic polymyxin B modulates P2X7 receptor function 210
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 208
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 203
Antigeni HLA e livelli sierici di HLA solubile nella malattia di Meniere 203
CYTOLYTIC P2X PURINOCEPTORS 202
In vitro studies during long-term oral administration of specific transfer factor 196
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 194
Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E+ cells 193
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 189
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 187
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 187
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 187
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II 185
Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells 184
Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Meniere's disease. 183
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 181
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 181
Utilizzo delle MSCs nel controllo del rigetto dei trapianti 180
An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes 179
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 178
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 177
P2 purinoceptors in the immune system 177
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 177
Allergic women have reduced sHLA-G plasma levels at delivery 176
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. 176
HLA B51 antigen associated with neutrophil hyper-reactivity 176
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report 176
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 176
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 175
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 175
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 175
A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells 175
New insights into HLA-G and inflammatory diseases 173
Analisi dei genotipi ed aplotipi HFE nella popolazione Ferrarese 170
MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region 170
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy 169
Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis. Is it a mechanism involved in the therapeutic effect of the procedure? 167
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 167
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 167
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 167
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 167
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 166
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 164
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 164
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 164
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 163
Frequenze genotipiche ed aplotipiche HFE nella popolazione della Provincia di Ferrara 161
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 161
Transfer factor in chronic mucocutaneous candidiasis 161
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: A role for HLA-G molecules 160
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 157
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 156
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 156
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 151
Ruolo dell’HLA-G nel mantenimento del privilegio immune dell’occhio. 150
Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. 150
Programmable binding of single microspheres to single target tumor cells using a dielectrophoresis (DEP) based “lab-on-a-chip” array. 149
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 149
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 148
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 147
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 146
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 145
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 144
Implication of immunosoppressive molecules during human oocyte maturation 142
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 139
Potential role of soluble HLA-G molecules in multiple sclerosis 139
Serological and molecular HLA typing in Italian Behcet's patients: significant association to B51-DR5-DQw3 haplotype 138
Can HLA-G predict disease course in rheumatoid arthritis patients? 136
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 133
In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment 133
The possible role of HLA-G molecules in human oocyte/embryo secretome 132
HLA-G expression and regulation in early embryos 131
Ruolo biologico dell'HLA-G solubile nella gravidanza. 131
Una nuova mutazione del gene HFE in un eterozigote C282Y con emocromatosi. 129
Totale 21.558
Categoria #
all - tutte 106.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 699
Totale 107.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.430 0 0 101 86 65 60 79 85 69 134 152 599
2022/20231.873 160 122 67 222 310 251 94 208 204 53 114 68
2023/20241.418 90 141 91 47 106 264 75 79 72 101 92 260
2024/20253.823 170 184 294 208 456 325 186 208 572 378 483 359
2025/20268.578 882 430 724 1.075 1.240 601 1.023 417 788 918 336 144
2026/20271.063 212 481 370 0 0 0 0 0 0 0 0 0
Totale 26.857